391 related articles for article (PubMed ID: 26911239)
1. Prussian blue nanoparticles and their analogues for application to cancer theranostics.
Patra CR
Nanomedicine (Lond); 2016 Mar; 11(6):569-72. PubMed ID: 26911239
[No Abstract] [Full Text] [Related]
2. Silver Prussian blue analogue nanomedicine for future cancer therapy.
Haque S; Patra CR
Future Oncol; 2021 Jan; 17(2):119-122. PubMed ID: 33244991
[No Abstract] [Full Text] [Related]
3. Biodegradable inorganic nanoparticles: an opportunity for improved cancer therapy?
Li L; Liu H
Nanomedicine (Lond); 2017 May; 12(9):959-961. PubMed ID: 28440705
[No Abstract] [Full Text] [Related]
4. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
5. Tailored ultra-small Prussian blue-based nanoparticles for MRI imaging and combined photothermal/photoacoustic theranostics.
Fétiveau L; Paul G; Nicolas-Boluda A; Volatron J; George R; Laurent S; Muller R; Sancey L; Mejanelle P; Gloter A; Gazeau F; Catala L
Chem Commun (Camb); 2019 Dec; 55(98):14844-14847. PubMed ID: 31768507
[TBL] [Abstract][Full Text] [Related]
6. Copper Prussian blue analogue: investigation into multifunctional activities for biomedical applications.
Mukherjee S; Rao BR; Sreedhar B; Paik P; Patra CR
Chem Commun (Camb); 2015 Apr; 51(34):7325-8. PubMed ID: 25820667
[TBL] [Abstract][Full Text] [Related]
7. Progress in Applications of Prussian Blue Nanoparticles in Biomedicine.
Qin Z; Li Y; Gu N
Adv Healthc Mater; 2018 Oct; 7(20):e1800347. PubMed ID: 29974662
[TBL] [Abstract][Full Text] [Related]
8. A Prussian Blue-Based Core-Shell Hollow-Structured Mesoporous Nanoparticle as a Smart Theranostic Agent with Ultrahigh pH-Responsive Longitudinal Relaxivity.
Cai X; Gao W; Ma M; Wu M; Zhang L; Zheng Y; Chen H; Shi J
Adv Mater; 2015 Nov; 27(41):6382-9. PubMed ID: 26393889
[TBL] [Abstract][Full Text] [Related]
9. Highly biocompatible, hollow coordination polymer nanoparticles as cisplatin carriers for efficient intracellular drug delivery.
Lian HY; Hu M; Liu CH; Yamauchi Y; Wu KC
Chem Commun (Camb); 2012 May; 48(42):5151-3. PubMed ID: 22514015
[TBL] [Abstract][Full Text] [Related]
10. [Supramolecular Agents for Theranostics].
Deyev SM; Lebedenko EN
Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
12. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cytomembrane-Cloaked Prussian Blue Nanoparticles Enhance the Efficacy of Mild-Temperature Photothermal Therapy by Disrupting Mitochondrial Functions of Cancer Cells.
Wang P; Kankala RK; Chen B; Zhang Y; Zhu M; Li X; Long R; Yang D; Krastev R; Wang S; Xiong X; Liu Y
ACS Appl Mater Interfaces; 2021 Aug; 13(31):37563-37577. PubMed ID: 34338525
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
15. Chondroitin sulfate derived theranostic nanoparticles for targeted drug delivery.
Varghese OP; Liu J; Sundaram K; Hilborn J; Oommen OP
Biomater Sci; 2016 Aug; 4(9):1310-3. PubMed ID: 27431007
[TBL] [Abstract][Full Text] [Related]
16. Biocompatible polymersomes-based cancer theranostics: Towards multifunctional nanomedicine.
Mohammadi M; Ramezani M; Abnous K; Alibolandi M
Int J Pharm; 2017 Mar; 519(1-2):287-303. PubMed ID: 28115259
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic Acid Conjugated Magnetic Prussian Blue@Quantum Dot Nanoparticles for Cancer Theranostics.
Yang Y; Jing L; Li X; Lin L; Yue X; Dai Z
Theranostics; 2017; 7(2):466-481. PubMed ID: 28255343
[TBL] [Abstract][Full Text] [Related]
19. Green Synthesized Nanomaterials as Theranostic Platforms for Cancer Treatment: Principles, Challenges and the Road Ahead.
Rajasekharreddy P; Huang C; Busi S; Rajkumari J; Tai MH; Liu G
Curr Med Chem; 2019; 26(8):1311-1327. PubMed ID: 28294042
[TBL] [Abstract][Full Text] [Related]
20. A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected].
Wang H; Agarwal P; Zhao S; Yu J; Lu X; He X
Nat Commun; 2015 Dec; 6():10081. PubMed ID: 26621191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
